My take is eventually if anyone wants to get paid they better find away forward and I think they will based on the science. These little ticks up($ value wise) usually coincide with those ridiculously priced restricted debentures that have in all farness kept them alive so far.  This time may be different and someone has taken a position personally to get ready for a swing up. Fresh blood that sees the opportunity and has some foresight with Epigentics and nothing to loose on the Big Pharma side. Volume proceeds price. Eversana bills themselves as working with the Big Pharma's. Maybe they can find such a party, dont know. DM is a lot of things which has been discussed add noxsium here. One good thing is he is a good at extracting money from stone if it is there- aka- horse trader. My opinion only. I am not saying a change at that top which would mean someone has come in that can forward plan is not what is happening. I am trying to look for a positive in this...Science. What he has to consider is as a founder he has to put all cards on the table. The next step may involve him relinquishing the CEO handle. Hope they find a way soon to settle on something meaningful to go forward with BTD.